Medhi Wangpaichitr

Under normoxia, 2-deoxy-<scp>d</scp>-glucose elicits cell death in select tumor types not by inhibition of glycolysis but by interfering with N-linked glycosylation

Metin Kurtoğlu, Ningguo Gao, Jie Shang et al. · Molecular Cancer Therapeutics · 2007 · 244 citations

Life Sciences, Cell Biology, Oncology +17

2-Deoxy-d-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion

Haibin Xi, Metin Kurtoğlu, Huaping Liu et al. · Cancer Chemotherapy and Pharmacology · 2010 · 206 citations · Full text

Life Sciences, Biochemistry, Cell Biology +15

Phase 2 study of pembrolizumab and circulating biomarkers to predict anticancer response in advanced, unresectable hepatocellular carcinoma

Lynn G. Feun, Yingying Li, Chunjing Wu et al. · Cancer · 2019 · 160 citations · Full text

Medicine, Oncology, Pharmacology +17

Overcoming cisplatin resistance by mTOR inhibitor in lung cancer

Chunjing Wu, Medhi Wangpaichitr, Lynn G. Feun et al. · Molecular Cancer · 2005 · 127 citations · Full text

Medicine, Molecular Biology, Oncology +17

Arginine Deiminase Resistance in Melanoma Cells Is Associated with Metabolic Reprogramming, Glucose Dependence, and Glutamine Addiction

Yan Long, Wen-Bin Tsai, Medhi Wangpaichitr et al. · Molecular Cancer Therapeutics · 2013 · 121 citations

Life Sciences, Molecular Biology, Oncology +16